UNSPSC 51282426: Ticarcillin cresyl sodium

This classification denotes an extended spectrum penicillin antibiotic with the molecular formula C22H21N2O6S2.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0EVR7Q3336, chemically known as p-tolyl (r)-n-((2s,5r,6r)-(2-carboxy-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)hept-6-yl))-3-thiophenemalonamate sodium salt, but more generally known as ticarcillin cresyl sodium, which bears US NIH Compound Identifier 42946.

European Medicines Agency schedules ticarcillin cresyl sodium or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB15567MIG. Most nations, for tariff purposes, schedule ticarcillin cresyl sodium under HS 29411090. SMILES: CC1CCC(CC1)OC(=O)[C@H](C2CCSC2)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)[O-].[NA+].

UNSPSC 51282426 Ticarcillin cresyl sodium, a Commodity code, does not match the recent state and local procurement activity tagged under it. The code nominally identifies a specific antibiotic pharmaceutical product, but the most-recent-opportunities block contains no solicitations for ticarcillin cresyl sodium itself. Instead, the tagged opportunities span naloxone procurement, pharmacy benefit program management, general medical and first aid supplies for emergency responders, and multi-source generic pharmaceuticals through cooperative purchasing. The mismatch suggests either a cataloging error in the source data or that state and local buying under this code has shifted materially away from the commodity's formal name. Based on the opportunities present, the code shows little relevant recent activity aligned to its nominal scope.

The four recent opportunities span different issuing bodies and geographies without a cohesive pharmaceutical procurement pattern under this code's nominal definition. Seminole County, Florida issued IFB 60459723LAS (posted June 30, 2026, due July 26, 2023) for naloxone and drug deactivation systems; the Texas Health and Human Services Commission issued RFI HHS0017013 (posted April 3, 2026) exploring direct-to-manufacturer pharmacy programs; the City of Tampa Purchasing Department issued IFB 26-P-00145 (posted March 25, 2026, due March 13, 2026) for medical and first aid supplies supporting the Tampa Fire Department Rescue Division at an estimated $700,000; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued RFP S1070000015802 (posted January 20, 2026, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed across state and local facilities in Minnesota and Oregon. None of these directly solicits the antibiotic named in the code, and their scope, issuing-body types, and geographic spread do not establish a coherent market signal for ticarcillin cresyl sodium procurement at state and local level.